Overview of the Alzheimer's Disease Pathology and Potential Therapeutic Targets
Trial Designs and Outcomes to Monitor Novel Therapeutics in Alzheimer's Disease
The Pharmacological Treatment of Alzheimer's Disease with Cholinesterase Inhibitors and Memantine
M1 Muscarinic Agonists: A Comprehensive Therapy Against Major Hallmarks of Alzheimer's Disease
Cholinergic Neurodegeneration in Alzheimer's Disease: Basis for Nerve Growth Factor Therapy
The Rationale for Glutamatergic Therapy in Alzheimer's Disease
Secretases as Pharmacological Targets in Alzheimer's Disease
?-Secretase as a Target for Alzheimer's Disease
The Rationale for an Immunological Approach to Alzheimer's Therapeutics
Neuroinflammation, Alzheimer Disease, and Other Aging Disorders
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Derived A?42-Lowering Molecules for Treatment and Prevention of Alzheimer's Disease (AD)
The Potential Application of Antioxidant Agents in Alzheimer Disease Therapeutics
Apolipoprotein E: A Potent Gene-Based Therapeutic Target for the Treatment of Sporadic Alzheimer's Disease
Tau Pathology as a Target in Alzheimer's Therapeutics
Design of Inhibitors of Amyloid-? Misfolding and Aggregation for Alzheimer's Therapy
Potential Applications of Glycosaminoglycan-Related Compounds in Alzheimer's Disease
Multifunctional Neuroprotective Drugs for the Treatment of Alzheimer's Disease
Interpreting Clinical Studies of Putative Therapeutics for Alzheimer's Disease: The Case of Statins and NSAIDs.